Specialty Otolaryngology
-
Featured
HPV-Associated Head and Neck Cancer Blood Test Shows Promise as Test to Replace Tissue Biopsy
A liquid biopsy test developed in the lab of Mass Eye and Ear researcher Dan Faden, MD, FACS, was more accurate, potentially faster and less costly than standard clinical workup for diagnosing HPV-associated head and neck cancer.
-
Artificial Intelligence Improves Diagnosis of Pediatric Middle Ear Effusion
Matthew G. Crowson, MD, MPA, MASc, Michael S. Cohen, MD, Christopher J. Hartnick, MD, and colleagues trained a neural network to diagnose pediatric middle ear effusion using a novel approach: the training set of images were tympanic membrane photos taken during myringotomy. When applied to a test set, the algorithm's diagnostic accuracy was 84%.
-
Novel Conjugated Molecule Shows Preclinical Potential to Treat Sensorineural Hearing Loss
Researchers at Mass Eye and Ear are part of the first team to establish that a small-molecule analog of neurotrophin-3 can promote inner ear neurite outgrowth and synaptogenesis in vitro, findings that have important implications for treatment of sensorineural hearing loss.
-
Discovery of New Molecular Player May Lead to Pathway for Hearing Loss Reversal
Dunia Abdul-Aziz, MD, and Albert Edge, PhD, researchers at Mass Eye and Ear, used a combination of genetic tools with inner ear organoid technology to identify new pathways involved in hair cell regeneration.
-
Scientists Identify Role of Protein Behind Rare Norrie Disease; Find Clues For Treating Hearing Loss
Albert Edge, PhD, and Yushi Hayashi, MD, PhD, of Mass Eye and Ear, have identified the mechanism that can lead to deafness in the rare syndrome, Norrie disease, and, in doing so, have revealed a pathway believed to be vital for hair cell regeneration.
-
Antibiotics Not Needed After Most Sinus Surgeries, Study Reports
Researchers Stacey T. Gray, MD, and Eric H. Holbrook, MD, of Mass Eye and Ear, worked with Marlene L. Durand, MD, of Massachusetts General Hospital and Mass Eye and Ear, to perform a randomized, double-blind clinical trial that compared the effect of the antibiotic amoxicillin-clavulanate on endoscopic sinus surgery patients to that of a placebo.
Otolaryngology–Head and Neck Surgery Contributors
-
Alan D. Workman, MD, MTR
Resident, Department of Otolaryngology–Head and Neck Surgery, Harvard Medical School
Recent Article
Department of Otolaryngology–Head and Neck Surgery Emerges as Global Leader in Early COVID-19 Research -
Albert Edge, PhD
Director, Tillotson Cell Biology Unit, Principal Investigator, Eaton-Peabody Laboratories, Mass Eye and Ear, Professor of Otolaryngology–Head and Neck Surgery, Harvard Medical School
Recent Article
Discovery of New Molecular Player May Lead to Pathway for Hearing Loss Reversal
-
Benjamin S. Bleier, MD
Director, Endoscopic Skull Base Surgery, Mass Eye and Ear, Claire and John Bertucci Chair in Otolaryngology, Associate Professor of Otolaryngology–Head and Neck Surgery, Harvard Medical School
Recent Article
Department of Otolaryngology–Head and Neck Surgery Emerges as Global Leader in Early COVID-19 Research
-
Dunia E. Abdul-Aziz, MD
Physician and Surgeon, Mass Eye and Ear, Instructor, Otolaryngology–Head and Neck Surgery, Harvard Medical School
-
Eric H. Holbrook, MD
Director, Division of Rhinology, Physician-Surgeon, Mass Eye and Ear, Associate Professor of Otolaryngology–Head and Neck Surgery, Harvard Medical School
Recent Article
Antibiotics Not Needed After Most Sinus Surgeries, Study Reports
-
Kristina Simonyan, MD, PhD, Dr med
Director, Laryngology Research, Mass Eye and Ear, Associate Professor of Otolaryngology–Head and Neck Surgery, Harvard Medical School
Recent Article
New Artificial Intelligence Platform Diagnoses Dystonia With Near-Perfect Accuracy
-
Neil Bhattacharyya, MD, MA, FACS
Physician-Surgeon, Mass Eye and Ear, Professor of Otolaryngology–Head and Neck Surgery, Harvard Medical School
Recent Article
Sleep Disorders Tally $94.9 Billion in Health Care Costs Each Year
-
Phillip A. Huyett, MD
Director of Sleep Surgery, Physician-Surgeon, Mass Eye and Ear, Clinical Instructor of Otolaryngology–Head and Neck Surgery, Harvard Medical School
Recent Article
Sleep Disorders Tally $94.9 Billion in Health Care Costs Each Year
-
Phillip C. Song, MD
Director, Division of Laryngology, Physician-Surgeon, Mass Eye and Ear, Assistant Professor of Otolaryngology–Head and Neck Surgery, Harvard Medical School
Recent Article
Department of Otolaryngology–Head and Neck Surgery Emerges as Global Leader in Early COVID-19 Research
-
Stacey T. Gray, MD
Director, Sinus Center, Mass Eye and Ear, Associate Professor of Otolaryngology–Head and Neck Surgery, Vice Chair of Otolaryngology Education, Harvard Medical School
Recent Article
Antibiotics Not Needed After Most Sinus Surgeries, Study Reports
Mass Eye and Ear/Mass General Otolaryngology–Head and Neck Surgery
A teaching hospital of Harvard Medical School, Mass Eye and Ear/Massachusetts General Hospital combines the expertise of highly specialized ear, nose, and throat physicians, audiologists, speech-language pathologists and auxiliary health care professionals to provide care for patients with problems affecting the ear, nose, throat, head and neck areas. The department, which is led by Chief and Chair Mark A. Varvares, MD, FACS, is one of the largest otolaryngology–head and neck surgery (OHNS) departments in the country, with more than 70 physicians staffed at 15 locations in the greater Boston area.